Endo News Roundup: T1 and T2 Diabetes Management

October 3, 2016

Three studies show the potential of an artificial pancreas & a less invasive glucose testing device and a 2-drug combo to improve glycemic measures.

A hybrid closed-loop insulin delivery system, or so-called “artificial pancreas,” appears to be safe and effective in patients with T1DM. A novel flash glucose testing device can reduce the time adults with well-controlled T1DM spend in hypoglycemia. A combination of exenatide and dapagliflozin can improve glycemic measures and cardiovascular risk factors better than either drug alone in patients with T2DM inadequately controlled on metformin monotherapy.